| ¿µ¹® | adverse effect | ÇÑ±Û | ¿ªÈ¿°ú, À¯ÇØÈ¿°ú |
|---|---|---|---|
| ¼³¸í | ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§ ³ªÅ¸³ª´Â Ä¡·á¸ñÀû¿¡ ºÎÇÕµÇÁö ¾Ê´Â ºÒÄèÇÑ ÀÛ¿ë, Áï ºÎÀÛ¿ëÀ» ¿ªÈ¿°ú·Î Ç¥ÇöÇÏ´Â °æ¿ì°¡ ÀÖ´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡¼´Â ¿ªÈ¿°ú¶õ ¡°¿¹¹æ, Áø´Ü, Ä¡·áÀÇ ¸ñÀûÀ¸·Î »ç¶÷¿¡°Ô »ó¿ë·®ÀÇ ¾àÀ» »ç¿ëÇÏ¿´À» ¶§ ¹ßÇöÇÏ´Â Àå¾Ö·Î, ÀǵµÇÏÁö ¾ÊÀº Àۿ롱À̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§, ƯÈ÷ ÁÖ¸ñÇÏ¿©¾ß ÇÒ ÀϹÝÀûÀÎ ¿ªÈ¿°ú·Î¼ ¾à¹°¾Ë·¹¸£±â, Á¶Ç÷Àå±â Àå¾Ö, °£-ÄáÆÏÀÇ Àå¾Ö, ¹°Áú ´ë»ç Àå¾Ö µîÀÌ ÀÖ´Ù. ÀÌ ¿Ü¿¡ ÀÓ»êºÎ¿¡°Ô Åõ¿©ÇÏ¿© ¹ß»ýÇÑ ±âÇü¹ß»ý, ¸¶¾à, °¢¼ºÁ¦, ±âŸ ÇâÁ¤½ÅÁ¦¿¡ ÀÇÇÑ ÀÇÁ¸¼º Çü¼ºµµ Áß¿äÇÏ´Ù. |
||
| ¿µ¹® | lead poisoning, saturinism | ÇÑ±Û | ³³Áßµ¶ |
|---|---|---|---|
| ¼³¸í | ¿ëÇØ¼º ³³À» ÈíÀÔÇϰųª »ïÅ´À¸·Î½á À¯¹ßµÇ´Â Á÷¾÷º´. ±Þ¼º°ú ¸¸¼ºÀÌ ÀÖÀ¸¸ç ´ë·®À¸·Î Èí¼öÇÏ¿© ±Þ¼º À§Àå¿° Áõ»óÀ» ³ªÅ¸³»´Â ±Þ¼º Áßµ¶Àº ¿ÀÈ÷·Á µå¹°°í, ±Ø¼Ò·®(1ÀÏ 1mg ÀÌÇÏ)ÀÇ ³³À» Àå±â°£ Áö¼ÓÀûÀ¸·Î ¼·ÃëÇÔÀ¸·Î½á »ý±â´Â ¸¸¼ºÀÌ ´õ ½É°¢ÇÏ´Ù. ³³Á¦·Ã¾÷-ȰÆÇÀμâ¾÷-µµÀå¾÷-³³À¯¸®Á¦Á¶¾÷-ÃàÀüÁöÁ¦Á¶¾÷ µî ³³ ¶Ç´Â ³³À» ÇÔÀ¯ÇÑ ¹°ÁúÀ» ´Ù·ç´Â »ç¶÷, ¶Ç °ú°Å¿¡´Â ¿¬¹éÀ» »ç¿ëÇÑ ºÐ¿¡ ÀÇÇÑ ÈÀåµ¶ÀÌ ¿©¼º¿¡°Ô ³ªÅ¸³ª ¹®Á¦°¡ µÇ¾úÀ¸³ª, ¿À´Ã³¯¿¡´Â °¡¼Ö¸°¿¡ È¥ÇÕµÈ ¾ÈƼ³ìÁ¦ÀÎ »ç¿¡Æ¿³³À¸·Î ÀÎÇÑ Áßµ¶ÀÌ ÁÖ¸ñµÇ°í ÀÖ´Ù. »ç¿¡Æ¿³³ Áßµ¶ÀÇ Áõ»óÀº ¿©·¯ °¡ÁöÀε¥, ºóÇ÷À̳ª ¶³¸®´Â Áõ»óÀÌ ºñ±³Àû Ãʱ⿡ ³ªÅ¸³ª°í ³³¼±(ÀÕ¸ö¿¡ ³³ÀÌ Ä§ÂøÇÏ¿© ûȸ¹é»öÀ¸·Î Âø»öµÈ´Ù)À̳ª ¹ßÀÛÀû º¹ÅëÀÌ Æ¯Â¡ÀÌ´Ù. ÀϹÝÀûÀ¸·Î ³³ÀÇ Áõ±â³ª °¡·ç°¡ ±âµµ¸¦ ÅëÇØ ü³»·Î µé¾î°¡´Â °æ¿ì°¡ µµ·á-¾È·á¿¡ µé¾î ÀÖ´Â ³³ÀÌ ÇǺγª ¼ÒȰüÀ» ÅëÇØ ħÅõÇÏ´Â Áõ·Êº¸´Ù Áõ»óÀÌ ½ÉÇÏ´Ù. |
||
| ¿µ¹® | food poisoning | ÇÑ±Û | ½ÄÁßµ¶ |
|---|---|---|---|
| ¼³¸í | À¯Çع°Áú¿¡ ¿À¿°µÈ À½½Ä¹°À» ¸ÔÀ½À¸·Î½á ÀϾ´Â ÀϱºÀÇ ±Þ¼ºÁúȯÀ̸ç, ÁÖ·Î ¹ß¿-±¸¿ªÁú-±¸Åä-¼³»ç-º¹Åë µîÀÇ Áõ¼¼°¡ ³ªÅ¸³´Ù. ÀÔÀ» ÅëÇÑ Àü¿°º´À̳ª ±â»ýÃæº´ µîÀº ¿©±â¿¡ Æ÷ÇÔµÇÁö ¾Ê´Â´Ù. ½ÄÁßµ¶À» ¿øÀι°Áú¿¡ µû¶ó ºÐ·ùÇÏ¸é ¼¼±Õ¼º ½ÄÁßµ¶, ÈÇмº ½ÄÁßµ¶, ÀÚ¿¬µ¶ ½ÄÁßµ¶, ¹Ì»ý¹° µ¶¼º´ë»ç¹°Áú¿¡ ÀÇÇÑ ½ÄÁßµ¶À¸·Î ±¸ºÐÇÒ ¼ö ÀÖ´Ù. °¢ ºÎ·ù¿¡ ¼ÓÇÏ´Â µ¶¼º¹°ÁúÀº ±× Á¾·ù°¡ ¸Å¿ì ¸¹À¸¸ç, µ¶¼º¹°ÁúÀº ´çÀå °Ç°À» ÇØÄ¥¸¸ÇÑ ¾çÀÌ ¾Æ´Ï¶ó ÇÏ´õ¶óµµ ¸¹Àº ½Äǰ Áß¿¡ ³Î¸® ºÐÆ÷µÇ¾î ÀÖ¾î¼ ¸¸¼ºÁßµ¶-¹ß¾Ï¼º-µ¹¿¬º¯ÀÌ À¯¹ß¼º-±âÇüÀ¯¹ß¼º-¾Ë·¹¸£±â¼º ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ¿øÀÎÀÌ µÉ ¼öµµ ÀÖ´Ù. ½ÄÁßµ¶ÀÇ ´ëºÎºÐÀº ¼¼±Õ¿¡ ÀÇÇÏ¿© »ý±â´Â ¼¼±Õ¼º ½ÄÁßµ¶À¸·Î¼, ¿©±â¿¡´Â »ì¸ð³Ú¶ó-Àåºñºê¸®¿À-À£Ä¡±Õ-º´¿ø´ëÀå±Õ¿¡ ÀÇÇÑ °¨¿°Çü ½ÄÁßµ¶°ú Æ÷µµ¾Ë±Õ, º¸Å縮´©½º±ÕÀÌ »ý¼ºÇÑ µ¶¼Ò¿¡ ÀÇÇÑ µ¶¼ÒÇü ½ÄÁßµ¶ÀÌ ÀÖ´Ù. °¨¿°Çü ½ÄÁßµ¶Àº »ì¾Æ ÀÖ´Â À¯Çؼ¼±ÕÀ» ´Ù·®À¸·Î ¸ÔÀ½À¸·Î½á ÀϾ´Â °ÍÀ̹ǷΠ½ÄǰÀ» °¡¿Çؼ ¸ÔÀ¸¸é ¼¼±ÕÀº »ç¸êÇØ ¹ö¸®±â ¶§¹®¿¡ Áßµ¶µÇ´Â ÀÏÀÌ ¾ø´Ù. ±×·¯³ª µ¶¼ÒÇü ½ÄÁßµ¶Àº ¼¼±ÕÀº Á׾ µ¶¼Ò´Â ±×´ë·Î ³²¾Æ ÀÖÀ¸¹Ç·Î À½½Ä¹°À» °¡¿Çصµ ³²Àº µ¶¼Ò°¡ Áßµ¶À» ÀÏÀ¸Å°´Â °æ¿ìÀÌ´Ù. ÈÇмº ½ÄÁßµ¶Àº ÈÇй°Áú¿¡ ÀÇÇÑ °ÍÀ¸·Î¼ ±Ù·¡¿¡ µé¾î¿Í ÈÇаø¾÷ÀÇ ¹ß´Þ·Î ÈÇÐÀû ÇÕ¼ºÇ°ÀÇ ´ë·®»ý»êÀÌ °¡´ÉÇØÁö°í À̵éÀÌ ½Äǰ°ø¾÷À̳ª ³ó¾÷ºÐ¾ß¿¡ ´Ù·®À¸·Î »ç¿ëµÇ¸é¼ ½É°¢ÇÑ ¹®Á¦·Î µîÀåÇÏ¿´´Ù. ƯÈ÷ ½Äǰ°¡°ø°úÁ¤ Áß¿¡ »ç¿ëÇÑ ºÒ¹ý½Äǰ÷°¡¹°, ÀÜ·ù³ó¾à-»ê¾÷Æó¼ö¿¡ ÀÇÇÑ ½ÄǰÀÇ Á߱ݼӿÀ¿°, ¶Ç´Â ½Äǰ°ú °ü·ÃÀÌ ÀÖ´Â °¢Á¾ ¿ë±â-±â±¸-Æ÷Àå µî¿¡¼ ¿ëÃâµÇ´Â µ¶¼º¹°ÁúÀÌ ¹®Á¦°¡ µÈ´Ù. |
||
| ¿µ¹® | carbon monoxide poisoning | ÇÑ±Û | ÀÏ»êÈź¼ÒÁßµ¶ |
|---|---|---|---|
| ¼³¸í | ÀÏ»êÈź¼ÒÀÇ ÈíÀÔ¿¡ ÀÇÇÏ¿© »êÈÇì¸ð±Û·ÎºóÀÌ Ä«¸£º¹½ÃÇì¸ð±Û·ÎºóÀ¸·Î º¯ÈÇÔÀ¸·Î½á ÀϾ´Â Áßµ¶. ÁßÃ߽Űæ°èÀå¾Ö¸¦ ÀÏÀ¸Å°°í Á×À½¿¡ À̸£±â°í ÇÑ´Ù. ÀÏ»êÈź¼Ò´Â ź¼Ò¸¦ ÇÔÀ¯ÇÑ À¯±â¹°ÀÌ ºÒ¿ÏÀü¿¬¼ÒÇÒ ¶§ ¹ß»ýÇÑ´Ù. µû¶ó¼ Á¦Ã¶, µµ½Ã°¡½º Á¦Á¶, °¡Á¤¿¡¼ ¹ß»ýÇϸç ÀÚµ¿Â÷ ¹è±â°¡½º¿¡µµ Æ÷ÇԵǾî ÀÖ°í °¡Á¤¿¡¼ ¿¬·áÀÇ ¿¬¼Ò¿¡ ÀÇÇØ¼µµ »ý±ä´Ù. ÀÏ»êÈź¼Ò¸¦ ÈíÀÔÇÏ¸é Æó¿¡¼ Ç÷¾×¼ÓÀÇ Ç÷»ö¼Ò¿Í °áÇÕÇÏ¿© ÀÏ»êÈź¼ÒÇì¸ð±Û·ÎºóÀ» Çü¼ºÇϰí, ÀÌ ¶§¹®¿¡ Ç÷¾×ÀÇ »ê¼Ò¿î¹Ý´É·ÂÀÌ »ó½ÇµÇ¾î ³»ºÎÀûÀÎ Áú½Ä»óÅ¿¡ ºüÁö°Ô µÈ´Ù. ÀÏ»êÈź¼Ò¿Í Çì¸ð±Û·Îºó°úÀÇ Ä£È¼ºÀº ±ØÈ÷ °ÇÏ¿© »ê¼Òº¸´Ù 250¹èÀÇ ¼¼±â·Î °áÇÕÇÑ´Ù. »ç¶÷¿¡ µû¶ó ÀÏ»êÈź¼Ò¿¡ ´ëÇÑ °¨¼ö¼ºÀÌ ´Ù¸£Áö¸¸, °ø±â ¼Ó¿¡ 0.001%¸¸ µé¾îÀ־ Áßµ¶À» ÀÏÀ¸Å²´Ù. ¶Ç 0.06%¿¡¼´Â 1½Ã°£¸¸ ÈíÀÔÇÏ¸é µÎÅëÀ» ÀÏÀ¸Å°°í 2½Ã°£ÀÌ¸é ½Ç½ÅÇÑ´Ù. ¶Ç 0.1%À» °æ¿ì´Â 1½Ã°£ À̳»¿¡ ½Ç½ÅÇϰí 4½Ã°£ÀÌ¸é »ç¸ÁÇÑ´Ù. Áßµ¶ Áõ¼¼´Â Á¶Á÷ÀÇ ¹«»ê¼ÒÁõ¿¡ ÀÇÇÑ °ÍÀ¸·Î¼, ±Þ¼ºÁßµ¶Àº ±Þ°ÝÈ÷ »ç¸ÁÇÏ´Â ¼öµµ ÀÖÁö¸¸, ´ë°³´Â óÀ½¿¡ µÎÅë-Çö±âÁõ-±Í¿ï¸²-±¸¿ª-±¸Åä µîÀÌ ÀÖ°í, »çÁöÀÇ ¿îµ¿ÀÌ ºÒ°¡´ÉÇÏ°Ô µÇ¸ç, ´Ù¼ÒÀÇ ÀǽÄÀÌ ³²¾Æ À־ ±×´ë·Î Á×À½¿¡ À̸£°Ô µÈ´Ù. Ÿ°¢ÀûÀ¸·Î´Â ¾ó±¼¿¡ È«Á¶¸¦ ¶ì°í Àü½Å¿¡ ¹«´Ì ¸ð¾çÀÇ ¹ßÀûÀÌ ³ªÅ¸³ª¸ç, È£ÈíÀÌ °¡´Ã°í ºÒ±ÔÄ¢ÇÏ°Ô µÈ´Ù. ÄÚ¸¦ °ñ°í ü¿ÂÀÌ ³»·Á°¡°í Àü½ÅÀÇ ±ÙÀ° À̿ µîÀÌ º¸À̸ç, È£Èí°ï¶õÀÇ Áõ¼¼°¡ º¸ÀÌÁö ¾Ê´Â Áß¿¡ È£ÈíÀÌ Á¤ÁöÇÏ°Ô µÈ´Ù. |
||
| ¿µ¹® | staphylococcal food poisoning | ÇÑ±Û | Æ÷µµ¾Ë±Õ ½ÄÁßµ¶ |
|---|---|---|---|
| ¼³¸í | Å©¸²ÀÌ µé¾î ÀÖ´Â °úÀÚ, Ä¿½ºÅ¸µå(custards), Ä¡Áî¿Í °°Àº ½ÄǰÀ̳ª, À°·ù¿¡ Ȳ»ö Æ÷µµ¾Ë±ÕÀÌ »ý¼ºÇϴ âÀÚ°üµ¶ÀÌ ÇÔÀ¯µÈ °ÍÀ» ¼·ÃëÇÏ¿© ÀϾ´Â ½ÄÁßµ¶À¸·Î¼ °©ÀÛ½º·¯¿î ¹ßº´, µÎÅë, ħºÐºñ, ±¸¿ª, ±¸Åä, ¼³»ç, º¹ºÎ»êÅë ¹× ¶¡³²À» Ư¡À¸·Î Çϸç, ¹ßÀÛ ÈÄ 5~6½Ã°£ Áö¼ÓÇÑ´Ù. |
||
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
|---|---|
| AML | Acute Myelogenous Leukemia Morphologic Classification(FABºÐ·ù) &n... |
| ADE | acute disseminated encephalitis; adverse drug event; antibody-dependent enhancement; apparent digest... |
| AML | acute monocytic leukemia; acute mucosal lesion; acute myeloblastic leukemia; acute myelocytic leukem... |
| PERLA | pupils equal, react to light and accommodation |
| ADE | Adverse Drug Event |
|---|---|
| ADR | Adverse Drug Reaction |
| DSP | Diarrhetic Shellfish Poisoning |
| PSP | Paralytic Shellfish Poisoning |
| RRE | REV response element |
acute angle
acute arthritis
acute monocytic leukemia
| adverse drug reaction reporting systems | Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions. (12 Dec 1998) |
|---|---|
| react | 1. To return an impulse or impression; to resist the action of another body by an opposite force; as, every body reacts on the body that impels it from its natural state. 2. To act upon each other; to exercise a reciprocal or a reverse effect, as two or more chemical agents; to act in opposition. Source: Websters Dictionary (01 Mar 1998) |
| gene products, rev | Trans-acting nuclear proteins whose functional expression are required for HIV viral replication. Specifically, the rev gene products are required for processing and translation of the HIV gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. Rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence (car) in env, also known as the rev-responsive element (rre), is responsive to the rev gene product. Rev is short for regulator of virion. (12 Dec 1998) |
| genes, rev | DNA sequences that form the coding region for a protein that regulates the expression of the viral structural and regulatory proteins in human immunodeficiency virus (HIV). Rev is short for regulator of virion. (12 Dec 1998) |
| rev | <molecular biology> A regulatory protein produced by HIV within infected cells. Rev helps transport HIV RNA sequences (messenger RNA) out from the nucleus into the cells cytoplasm, where it directs construction of proteins for new virus particles. (11 Jan 1998) |
| drug-drug interaction | The effects that occur when two or more drugs are used together. Such effects include changes of absorption in the digestive tract, changes in rate of the drugs' breakdown in the liver, new or enhanced side effects and changes in the drugs' activity. (09 Oct 1997) |
| adverse | Harmful. (18 Nov 1997) |
| adverse effect | This is an abnormal or harmful effect to an organism caused by exposure to a chemical. It is indicated by some result such as death, a change in food or water consumption, altered body and organ weights, altered enzyme levels, or visible illness. An effect may be classed as adverse if it causes functional or anatomical damage, causes irreversible change in the homeostasis of the organism, or increases the susceptibility of the organism to other chemical or biological stress. A non-adverse effect will usually be reversed when the organism is no longer being exposed to the chemical. (09 Oct 1997) |
| adverse event | A toxic reaction to a medical therapy. (09 Oct 1997) |
| adverse reaction | Any undesirable or unwanted consequence of a preventive, diagnostic, or therapeutic procedure or regimen. (05 Mar 2000) |
| no-observed-adverse-effect level | The highest dosage administered that does not produce toxic effects. The noael will depend on how closely dosages are spaced (lowest-observed-adverse-effect level and no-observed-effect level) and the number of animals examined. The ultimate objective is usually to determine not the "safe" dosage in laboratory animals but the "safe" dosage for humans. Therefore, the extrapolation most often required of toxicologists is from high-dosage studies in laboratory animals to low doses in humans. (casarett and doull's toxicology: the basic science of poisons, 4th ed) (12 Dec 1998) |
| event, adverse | In pharmacology, an adverse event is any unexpected or dangerous reaction to a drug. (12 Dec 1998) |
| ackee poisoning | An acute and frequently fatal vomiting disease associated with central nervous system symptoms and marked hypoglycaemia, caused by eating unripe ackee fruit of Blighia spaida, a tree common in Jamaica. Synonym: Jamaican vomiting sickness. (05 Mar 2000) |
| arsenic poisoning | A severe poisoning that occurs after the exposure (ingested or inhaled). Signs and symptoms include: nausea, vomiting, diarrhoea, rapid heart rate, apprehension and difficulty breathing. (27 Sep 1997) |
| bacterial food poisoning | A term commonly used to refer to conditions limited to enteritis or gastroenteritis (excluding the enteric fevers and the dysenteries) caused by bacterial multiplication per se or by a soluble bacterial exotoxin. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|